Abstract Comparative genomic hybridization was used to identify chromosomal imbalances in eight cell lines and 12 blood samples from patients with adult T-cell leukemia/ lymphoma (ATL). The chromosomes most often over-represented in the cell lines were 2p (6 cases), 7q (4 cases), and 14q (4 cases), with minimal common regions at 2p16-22, 7q21-36, and 14q32, respectively. Distinct imbalances were detected in only 7 of the clinical samples. Chromosomes 14q32 and 2p16-22 harbor TCL1 and a transcription factor, HTLF (human T-cell leukemia virus enhancer factor), respectively. FISH analysis revealed that TCL1 did not juxtapose to TCRA, and we detected no expression of TCL1 in any of the ATL cell lines despite the 14q32 amplifications. Moreover, expression of HTLF was not elevated in the ATL cell lines bearing multiplication of 2p. These results suggest that chromosomal regions 2p16-22 and 14q32 harbor genes other than HTLF and TCL1 that are involved in cellular immortalization or in the pathogenesis of ATL.
Introduction
Adult T-cell leukemia/lymphoma (ATL) is defined on the basis of clinical manifestations that include distinct morphology of abnormal lymphocytes, T-cell markers, and an association with HTLV-1 virus infection (Hinuma et al. 1982; Seiki et al. 1984) . However, a lack of distinctive oncogenes in the HTLV-I genome (Seiki et al.1983 ) and the fact that ATL occurs in a very small proportion (0.01%-0.02%) of individuals infected with HTLV-1 (Seiki et al. 1983) imply that additional genetic changes may be required for the onset of the disease.
Various cytogenetic aberrations have been reported in ATL, such as trisomies of chromosomes 3, 7, and 21, deletions of chromosomes 6q, 3q, and 10p, and translocations involving 14q32 or 14q11 (Kamada et al. 1992) . However, the karyotypes are often complex, with widespread alterations throughout various chromosomes, a feature that complicates efforts to identify consistent aberrations that might include distinct copy-number changes with potential diagnostic or prognostic significance.
Comparative genomic hybridization (CGH) is a valuable procedure for whole-genome scanning because it allows identification of chromosomal imbalances such as gains, losses, or amplifications of DNA sequences in entire tumor genomes (Kallioniemi et al. 1993) . Because copy-number changes are detected by CGH only if they are present in at least 50% of the cells, this method can identify consistent clonal aberrations associated with tumor development or progression (Kallionemi et al. 1993 ). However, we are aware of no published reports of CGH analyses in ATL.
We performed CGH to identify genomic imbalances in peripheral blood mononuclear cells (PBMCs) from patients with acute-type ATL and in cell lines derived from ATL.
The cell lines we examined showed preferential over-representation indicative of gene multiplication and/or amplification in chromosomal regions 14q32 and 2p16-22. Chromosome 14q32 harbors TCL1, a gene that is sometimes juxtaposed to TCRA or TCRD in peripheral T-cell lymphocytic leukemia (PTLL) (Virgilio et al. 1993 (Virgilio et al. , 1994 ; a transcriptional factor, HTLF (human T-cell leukemia virus enhancer factor) lies on 2p16-22 (Li et al. 1992) . To investigate the possible involvement of these two genes in the pathogenesis of ATL, we examined our panel of cells for rearrangement and/or coamplification of TCL1 with TCRA, and determined the expression status of TCL1 and HTLF in the same cell preparations.
Materials and methods

Samples
Characteristics of eight cell lines and PBMCs isolated from 12 clinical cases of acute-type ATL are listed in Table 1 . All these patients showed more than 70% of leukemic cells typical of ATL in the peripheral blood, respectively. Details concerning five of the cell lines (HUT78, ATL-5T, SD-4, KPNT-1, and IPAT-1) have been described elsewhere (Miyamoto et al. 1987; Tatewaki et al. 1995; Takizawa et al. 1998) ; the other three cell lines (OMT-1, KK-1, and ST-1) were newly established by Y. Yamada (Dept. of Clinical Laboratories, Nagasaki University Hospital) and Y. Kagami (Dept. of Hematology and Chemotherapy, Aichi Cancer Center Hospital) from PBMCs of untreated ATL patients, and will be described elsewhere. Among them, six (OMT-1, KK-1, SD-4, KPNT-1, IPAT, and ST-1) required medium containing IL-2 for passage (Table 1) . PBMCs from 12 patients diagnosed with acute ATL were isolated by density gradient centrifugation using Ficoll/Hypaque (Pharmacia LKB, Uppsala, Sweden). Diagnoses were made on the basis of clinical features, hematological findings, and serum anti-HTLV-1 antibodies according to the criteria described by Shimoyama et al. (1991) . Clonal integration of HTLV-1 DNA into the host genome was investigated by Southern blot analysis in all cases as described (Kagami et al. 1993 ).
Comparative genome hybridization (CGH)
Genomic DNAs were isolated from leukemic cells and from PBMCs of healthy donors with the conventional method. CGH was performed as described elsewhere (Kallioniemi et al. 1993; Ariyama et al. 1998a) . Briefly, tumor (test) DNA and normal DNA were labeled by nick-translation with Spectrum Green-dUTP (Vysis, Boston, MA, USA) and Texas Red-dUTP (NEN-Dupont, Boston, MA, USA), respectively. Equal amounts (180 ng) of tumor and normal DNAs were mixed with 15 µg of human Cot-1 DNA (Gibco/ BRL, Gaithersburg, MD, USA), resuspended in hybridization mixture, and hybridized in situ to human metaphase chromosome spreads prepared from phytohemagglutinin (PHA)-stimulated lymphocytes of a normal male volunteer.
After hybridization, the slides were washed and the chromosomes counter-stained with 4Ј,6Ј-diamino-2-phenylindol (DAPI) to permit identification of the chromosomes.
Fluorescent hybridization signals and DAPI-staining patterns were captured with a cool chargecoupled device (CCD) camera (Photometrics, Tucson, AZ, USA) attached to a Nikon microscope (Ecrips E600) and processed using a Quips image analysis system (Vysis). The manufacturer's software calculated the green (tumor DNA)-to-red (normal DNA) fluorescent ratio along the length of each chromosome. Averaged readings from at least six chromosomes were graphed for each chromosome and compared with the profile for the same chromosome in a reference hybridization to set the boundaries of gain and loss (Sakakura et al. 1999) . Heterochromatic regions near the centromeres, and the entire Y chromosome, were excluded from analysis.
Two-color fluorescent in situ hybridization (FISH)
Our CGH analysis of the ATL cell lines showed preferential multiplication at 14q32, a chromosomal region harboring TCL1. Frequent translocations or inversions involving the TCRA/D loci and TCL1, such as t(14;14)(q11;q32.1) and inv(14)(q11;q32.1), are observed in PTLL (Virgilio et al. 1993 (Virgilio et al. , 1994 . Therefore, to verify copy-number changes and detect possible rearrangements of TCL1 and TCRA in our series of ATL samples, we performed two-color FISH, using as probes cosmids specific for TCL1 (pLC1; 14q32) and TCRA (Plcos22, 14q11) (Narducci et al. 1995) . Probe labeling, in situ hybridization, and signal evaluation were performed as described previously (Inazawa et al. 1994) . Briefly, Plcos22 was labeled with digoxigenin-11-dUTP (Boehringer, Indianapolis, IN, USA), and PLC1 with biotin-16-dUTP (Boehringer), by nick-translation. Labeled probes were precipitated with sonicated salmon sperm DNA and dissolved in 20 µl of formamide. The probe solutions were mixed with Cot 1 DNA (250 ng/µl), and denatured before addition of hybridization buffer. Signals were detected by antidigoxigenin rhodamine and avidin-FITC. After being counterstained with DAPI, the slides were examined through a Nikon Eclipse epifluorescent microscope equipped with a CCD camera (Photometrics). Images were captured with Quips (Vysis) software and processed with Adobe Photoshop 3.0 software as described elsewhere (Ariyama et al. 1998b ).
Reverse transcriptase-polymerase chain reaction (RT-PCR)
RNAs were isolated from the ATL cell lines using TRIzol reagent (Gibco BRL). In each case, cDNA was prepared from total RNA using random primer oligonucleotides. Approximately 5 µg of RNA in a final volume of 11 µl was first denatured at 70°C for 10 min and then cooled on ice. First-strand DNA synthesis was performed by adding 1 µl 1p13, 4p16, 8q24, 10p15, 14q32, 19p13.3, 20p13, (Han et al. 1995) . TCL1-specific primers used for the PCR were TCL1-U1 (5Ј-AGGCCTATGACCCCCACC-3Ј), corresponding to the (ϩ) strand from bp 222-239, and TCL1-R2 (5Ј-CATTCCTCCCAGACCCCA-3Ј), corresponding to the (Ϫ) strand from bp 511-529 of the TCL1 cDNA. The TCL1-specific product corresponded to 308 bp Narducci et al. (1997) . HTLF-specific primers were HTLF-2F (5Ј-CACCAACAGGCTGGAAGAAT-3Ј), corresponding to the (ϩ) strand from bp 466-485, and HTLF-R2 (5Ј-GGATCAATGCTGGTGGCTAA-3Ј), corresponding to the (Ϫ) strand from bp 885-904 of HTLF cDNA. The HTLF-specific product corresponded to 439 bp (Li et al. 1992) . Primers specific for control amplification of a housekeeping gene ( -actin) were ACTIN-S (5Ј-CCAGAGATGGCCACGGCTGCT-3Ј) and ACTIN-AS (5Ј-TCCTTCTGCATCCTGTCGGCT-3Ј). Amplifications were performed at 94°C for 30 s, 60°C for 30s, and 72°C for 30s for 25 (TCL1), 30 (HTLF), or 25 cycles ( -actin). RT-PCR products were electrophoresed through a 3.0% GTG agarose, Southern-blotted onto a nylon membrane, and hybridized with 32 P-labeled internal oligonucleotides internal to the PCR products specific for TCL1 or HTLF.
Results
Copy-number changes detected by CGH
All the clinical samples and cell lines were successfully analyzed by CGH. In 5 of the 12 primary samples we found no copy-number changes, but in the other 7 patients and all eight cell lines, distinct copy-number changes were identified by CGH analysis (Table 1) . A schematic summary is shown in Fig. 2 . The most commonly gained regions in the cell lines were at 2p (6/8), 7q (4/8), and 14q (4/8), with the minimal common regions at 2p16-22, 7q21-36, and 14q32, respectively (Figs. 1,2) . High-level gains (HLGs) indicative of genomic amplifications were detected at 2p16-25 in three cell lines (HUT-78, SD-4, and KK-1), and in one line each at 9q33-34 (HUT-78), 12p11.2-13 (ATL-5T), and 14q31-32 (OMT-1). However, no frequent common regions for copynumber gains or losses could be detected among the clinical samples.
FISH with TCL1 and TCRA-specific cosmids
To identify the status of TCL1 amplification and to ascertain a possible juxtaposition of TCL1 to TCRA, we performed two-color FISH to metaphase and interphase chromosomes with cosmids specific for TCL1 (PLC1) and TCRA (PLC22) in the four ATL cell lines that had exhibited overrepresentations at 14q32 (HUT78, SD-4, ST-1, and OMT-1). In these experiments, at least 65 interphase nuclei and 20 metaphase cells were observed and scored in each cell line examined (data not shown). A typical pattern of FISH, using metaphase chromosomes of OMT-1, is shown in Fig. 3 . TCL1 was multiplied to more than three copies in each of the four cell lines, a result in accord with the results obtained by CGH. However, we observed no fusion of the signals for TCL1 and TCRA that would indicate TCL1/ TCRA rearrangement in either interphase or metaphase cells (Fig. 3) .
Expression of TCL1 and HTLF
To evaluate expression of the TCL1 gene, we performed RT-PCR assay of mRNAs from each of the ATL cell lines, using human fetal thymocytes and a leukemic cell line (BV173) as positive controls (Virgilio et al. 1994) . No TCL1 expression was detected in any ATL cell line whether or not it had shown 14q32-multiplication, even though we employed an autoradiographic exposure of 2 days (Fig. 4a) . We did however detect TCL1 in human fetal thymocytes and in BV173, in agreement with results reported by Virgilio L. et al. (1994) .
To investigate whether the HTLF gene was expressed in ATL cell lines with or without multiplication of 2p16-p25, the site of the HTLF locus, we analyzed mRNAs from the ATL cell lines, and from Jurkat and normal lymphocytes, in RT-PCR assay. HTLF expression was detected in six of the ATL cell lines (KK-1, HUT78, SD-4, OMT-1, KPNT-1, and ST-1) and in Jurkat and normal lymphocytes, but not in ATL-5T or IPAT-1 (Fig. 4b) .
Discussion
Overrepresentation or HLG of chromosomes 7q, 14q32, and 2p16-22 were the most prominent features among the ATL-derived cells in our study. Of them, trisomy 7 has been reported to be one of the frequent chromosome aberrations of ATL in extensive cytogenetic studies (Kamada et al. 1992) . Our data confirmed the previous results and suggest 3 . Two-color FISH with cosmids specific for TCRA (rhodamine; pink signals) and TCL1 (FITC; green signals) on metaphase chromosomes from OMT-1, revealing high-level amplification at 14q32 (see Fig. 3 ). TCL1 did not juxtapose to TCRA in any cells, although the TCL1 locus was multiplied to four copies that the long arm of chromosome 7 might contain the gene(s) responsible for the pathogenesis of ATL by a mechanism of the gene dosage effect.
Multiplication of 14q32 seems to be important, because it was present in four of eight cell lines and also in one clinical case. The TCL1 oncogene lies at 14q32, where it is involved in the specific cytogenetic rearrangements, such as t(14;14)(q11;q32.1) and inv(14)(q11;q32.1), that occur frequently in mature peripheral T-cell leukemias (Virgilio et al. 1993 (Virgilio et al. , 1994 . As a consequence of these rearrangements, regulation of the TCL1 proto-oncogene is disrupted by its juxtaposition to the enhancer element of the TCRA gene. This oncogenic stimulation is considered to be an early event in the development of T-cell neoplasms (Narducci et al. 1995) . Recent molecular and immunocytochemical analyses have revealed that TCL1 is overexpressed in ATL in comparison to normal T cells, and also in T-cell lines derived from patients with T-acute lymphocytic leukemia (T-ALL) (Narducci et al. 1997) . More recently, the same group of investigators has isolated a new member of the TCL1 gene family, TCL1b, which is localized approximately 16 kb centromeric of TCL1 (Pekarsky et al. in press) . These results have suggested that this gene might play a critical role in the pathogenesis of ATL (Narducci et al. 1997; Pekarsky et al. in press) . Our FISH results, on the contrary, showed that TCL1 did not juxtapose to TCRA in any of the four cell lines that exhibited multiplication at 14q32. Furthermore, TCL1 expression was undetectable in any of the cell lines we examined, whether they exhibited multiplication at 14q32 or not. These results strongly suggest that one or more oncogenes on 14q32 other than TCL1, upregulated by mechanisms of amplification or gene dosage effect, might be responsible for the leukemogenesis leading to ATL.
Overrepresentation of 2p16-22 also seems to be important in the immortalization of leukocytes or the pathogenesis of ATL, because we detected it in six of our eight cell lines. HTLF, a cellular factor that binds to the long terminal repeat (LTR) in HTLV-I, has been mapped to human chromosome 2p16-22 (Li et al. 1992) . Genomic amplification of a gene often results in its overexpression, and therefore it is plausible to assume that the multiplication of HTLF provides a signal responsible for development of ATL. In particular, the regulatory protein "tax" of HTLV-1 positively regulates the transcription of the viral genome as well as specific cellular genes, and it shows a weak oncogenic activity in vitro (Tanaka et al. 1990; Franchini 1995) . Tax protein does not bind directly to the HTLV-1 LTR, but it serves as a potential transcriptional transactivator of the cellular factors that do specifically bind the LTR (Yoshida et al. 1995; Fujisawa et al. 1985) . Therefore, if HTLF is localized within 2p22, HTLF is a reasonable candidate for involvement in the pathogenesis of ATL, like other cellular factors (e.g., IL2, IL2R, IL3, IL6, CSF2, TNFA, TNFB, FOS, and NFKB) whose expression can be induced by "tax" (Yoshida et al. 1994) . However, our quantitative RT-PCR analysis showed that expression of HTLF was not preferentially elevated in our ATL cell lines despite genomic multiplication of 2p16-22, as judged by comparison to its expression in Jurkat or normal lymphocytes. Since in our experiments genomic multiplication of 2p16-22 did not necessarily result in overexpression of HTLF, this chromosomal region also Fig. 4a,b. RT-PCR of the TCL1 (a) and HTLF (b) gene products. a Top: Southern blot hybridization. Bottom: ethidium bromide staining of the RT-PCR performed withactin primers. No TCL1 expression could be detected in ATL cell lines with 14q32 multiplication (OMT-1, SD-4, ST-1, HUT78) or without 14q32 multiplication (IPAT-1, KK-1, KPNT-1, ATL-5T). Human fetal thymocytes and BV173 were positive controls for expression of TCL1 (Virgilio et al. 1994 ). Autoradiography was carried out for 2 days. b HTLF was expressed in six of the eight ATL cell lines (KK-1, HUT78, SD-4, OMT-1, KPNT-1, and ST-1), and in Jurkat and normal lymphocytes, but not in ATL-5T or IPAT-1. Asterisk indicates the cell lines exhibited chromosomal gains of 2p16-p22 by CGH may harbor some other gene(s) that confer the specific biological aspects of pathogenesis in ATL. We observed preferential gains in copy number of 2p16-22 in five of the six cell lines that grew in an IL2-dependent manner; therefore, this chromosomal region must contain a gene(s) encoding protein(s) serving through the IL2-dependent signaling pathway.
Our data indicate that more detailed analyses are required to clarify whether unknown candidate oncogenes for ATL lie within chromosomal regions 14q32 and 2p16-22.
